HFSA Scientific Meeting 2021: CME Course Addresses Disparities in Diagnosis & Treatment of Heart Failure in Women
Check out recent PlatformQ Health News
Advances in disease-modifying therapies for multiple sclerosis can improve the quality of life of patients - yet rapid changes to the treatment landscape left knowledge gaps among providers and patients. In addition, for patients to play a role in their own making, they also need to understand treatment options, side...
COVID-19 has not dampened healthcare providers’ interest or need in engaging in peer to peer education. A recent survey found 88% of providers are looking to hear about new treatments, either through all virtual or a mix of virtual and in-person meetings, even after the pandemic wanes. Yet the majority...
Emerging treatments such as anti-GD2 therapies are improving outcomes for children with relapsed/refractory, high-risk neuroblastoma. The changing therapeutic landscape has left knowledge gaps, with clinicians needing assistance with understanding how to integrate new agents, administer new treatments, and manage associated side effects. To address these issues, PlatformQ Health teamed up...
Clinicians Love Learning with PlatformQ Health
This activity has allowed me to better do a differential diagnosis between various neuropathies, some of them very similar in symptom presentation.
Clinician learners after participating in Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
After viewing these presentations, I can make use of more tools and alternatives to better explain their disease, and to talk with my patients about other treatment approaches.
Clinician learners after participating in AHA Conference Coverage Heart Failure Virtual Symposium (Clinical Spotlight on Novel Interventions for Patients with Heart Failure)
I am better at adjusting insulin therapy and individualizing the diabetic program for the patient.
Clinician, after participating in Long-acting Insulins In Treatment Of T2dm: Aligning Provider & Patient Perspectives To Address Therapeutic Barriers
I am more competent in prescribing the appropriate drugs. I also know how to involve my patients in health decisions to minimize non adherence.
Clinician, after participating in HIV Update: Adherence Advances with New ART Formulations
Leverage Our Learning Platform
Learn more about the PlatformQ Health Education solution and how to support CME/CE.